Literature DB >> 18031839

Diets influence the diabetic phenotype of transgenic mice expressing a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPRdn).

Nadja Herbach1, Burkhard Göke, Eckhard Wolf, Ruediger Wanke.   

Abstract

Transgenic mice overexpressing a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPR(dn)) have recently been shown to develop diabetes mellitus due to disturbed postnatal development of the endocrine pancreas. In this study, the effects of feeding a high fibre/low calorie diet on the diabetic phenotype of GIPR(dn) transgenic mice were examined. Transgenic and control animals received either a conventional breeding diet (BD) or a high fibre diet (HF). Both fasting and postprandial blood glucose levels and HbA1C levels were largely elevated in transgenic mice vs. controls (p<0.05), irrespective of the diet fed. Food and water intake and the daily urine volume of GIPR(dn) transgenic mice were higher than that of control mice (p<0.05). Transgenic animals receiving the HF diet showed significantly lower blood glucose and HbA1C levels as well as less food and water intake than transgenic mice fed BD. The 365-day survival of transgenic mice was significantly lower than that of control mice. Transgenic animals fed the HF diet lived significantly longer than their counterparts receiving BD. GIPR(dn) transgenic mice develop a severe diabetic phenotype which can be ameliorated by a HF diet, thereby resembling some aspects of the pathophysiology of human type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031839     DOI: 10.1016/j.regpep.2007.10.005

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

Review 1.  [Pathogenesis of diabetes mellitus and diabetic complications. Studies on diabetic mouse models].

Authors:  N Herbach
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

2.  Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice.

Authors:  Nadja Herbach; Martina Bergmayr; Burkhard Göke; Eckhard Wolf; Ruediger Wanke
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.